BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11239501)

  • 1. Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells.
    Takeuchi T; Tsuboi T; Arai M; Togari A
    Biochem Pharmacol; 2001 Mar; 61(5):579-86. PubMed ID: 11239501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel molecular mechanism modulating osteoclast differentiation and function.
    Yasuda H; Shima N; Nakagawa N; Yamaguchi K; Kinosaki M; Goto M; Mochizuki SI; Tsuda E; Morinaga T; Udagawa N; Takahashi N; Suda T; Higashio K
    Bone; 1999 Jul; 25(1):109-13. PubMed ID: 10423033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells.
    Nakagawa N; Yasuda H; Yano K; Mochizuki Si; Kobayashi N; Fujimoto H; Shima N; Morinaga T; Chikazu D; Kawaguchi H; Higashio K
    Biochem Biophys Res Commun; 1999 Nov; 265(1):158-63. PubMed ID: 10548507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation.
    Nagai M; Sato N
    Biochem Biophys Res Commun; 1999 Apr; 257(3):719-23. PubMed ID: 10208850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of parathyroid hormone-related protein (PTHrP), osteoclast differentiation factor (ODF)/receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoclastogenesis inhibitory factor (OCIF)/osteoprotegerin (OPG) in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2004 Jan; 33(1):46-52. PubMed ID: 14675140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis.
    Tsurukai T; Udagawa N; Matsuzaki K; Takahashi N; Suda T
    J Bone Miner Metab; 2000; 18(4):177-84. PubMed ID: 10874596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture.
    Koshihara Y; Hoshi K; Okawara R; Ishibashi H; Yamamoto S
    J Endocrinol; 2003 Mar; 176(3):339-48. PubMed ID: 12630919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation.
    Suda K; Udagawa N; Sato N; Takami M; Itoh K; Woo JT; Takahashi N; Nagai K
    J Immunol; 2004 Feb; 172(4):2504-10. PubMed ID: 14764723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture.
    Komine M; Kukita A; Kukita T; Ogata Y; Hotokebuchi T; Kohashi O
    Bone; 2001 May; 28(5):474-83. PubMed ID: 11344046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S
    Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors.
    Kikuchi T; Matsuguchi T; Tsuboi N; Mitani A; Tanaka S; Matsuoka M; Yamamoto G; Hishikawa T; Noguchi T; Yoshikai Y
    J Immunol; 2001 Mar; 166(5):3574-9. PubMed ID: 11207318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.
    Hofbauer LC; Khosla S; Dunstan CR; Lacey DL; Boyle WJ; Riggs BL
    J Bone Miner Res; 2000 Jan; 15(1):2-12. PubMed ID: 10646108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells.
    Murakami T; Yamamoto M; Ono K; Nishikawa M; Nagata N; Motoyoshi K; Akatsu T
    Biochem Biophys Res Commun; 1998 Nov; 252(3):747-52. PubMed ID: 9837778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures.
    Matsuzaki K; Udagawa N; Takahashi N; Yamaguchi K; Yasuda H; Shima N; Morinaga T; Toyama Y; Yabe Y; Higashio K; Suda T
    Biochem Biophys Res Commun; 1998 May; 246(1):199-204. PubMed ID: 9600092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.
    Kotake S; Udagawa N; Takahashi N; Matsuzaki K; Itoh K; Ishiyama S; Saito S; Inoue K; Kamatani N; Gillespie MT; Martin TJ; Suda T
    J Clin Invest; 1999 May; 103(9):1345-52. PubMed ID: 10225978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro.
    Chikatsu N; Takeuchi Y; Tamura Y; Fukumoto S; Yano K; Tsuda E; Ogata E; Fujita T
    Biochem Biophys Res Commun; 2000 Jan; 267(2):632-7. PubMed ID: 10631114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
    Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT
    J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.